Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LAE-005 by Laekna for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
LAE-005 is under clinical development by Laekna and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...